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Summary
Objective: The aim of the present pilot study is to show initial results of a multimodal approach using clinical scoring, morphological magnetic
resonance imaging (MRI) and biochemical T2-relaxation and diffusion-weighted imaging (DWI) in their ability to assess differences between
cartilage repair tissue after microfracture therapy (MFX) and matrix-associated autologous chondrocyte transplantation (MACT).
Method: Twenty patients were cross-sectionally evaluated at different post-operative intervals from 12 to 63 months after MFX and 12e59
months after MACT. The two groups were matched by age (MFX: 36.0 10.4 years; MACT: 35.1 7.7 years) and post-operative interval
(MFX: 32.6 16.7 months; MACT: 31.7 18.3 months). After clinical evaluation using the Lysholm score, 3 T-MRI was performed obtaining
the MR observation of cartilage repair tissue (MOCART) score as well as T2-mapping and DWI for multi-parametric MRI. Quantitative T2-re-
laxation was achieved using a multi-echo spin-echo sequence; semi-quantitative diffusion-quotient (signal intensity without diffusion-weighting
divided by signal intensity with diffusion weighting) was prepared by a partially balanced, steady-state gradient-echo pulse sequence.
Results: No differences in Lysholm (P¼ 0.420) or MOCART (P¼ 0.209) score were observed between MFX and MACT. T2-mapping showed
lower T2 values after MFX compared to MACT (P¼ 0.039). DWI distinguished between healthy cartilage and cartilage repair tissue in both
procedures (MFX: P¼ 0.001; MACT: P¼ 0.007). Correlations were found between the Lysholm and the MOCART score (Pearson: 0.484;
P¼ 0.031), between the Lysholm score and DWI (Pearson:0.557; P¼ 0.011) and a trend between the Lysholm score and T2 (Person:
0.304; P¼ 0.193).
Conclusion: Using T2-mapping and DWI, additional information could be gained compared to clinical scoring or morphological MRI. In com-
bination clinical, MR-morphological and MR-biochemical parameters can be seen as a promising multimodal tool in the follow-up of cartilage
repair.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Articular cartilage lesions are a common pathology of the
knee joint, and there are many patients who might beneﬁt
from cartilage repair1. Particularly for young people with car-
tilage defects, the emergence of clinically applicable thera-
pies for biological joint reconstruction is appealing. Two
widely used techniques are microfracture therapy (MFX)
and matrix-associated autologous chondrocyte transplanta-
tion (MACT). MFX is a one-step arthroscopic approach*Address correspondence and reprint requests to: Prof. Dr.
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1219where cartilage repair tissue is differentiated from a bone
marrow clot after multiple perforations of the subchondral
bone plate2,3. MACT, a third-generation, autologous chon-
drocyte transplantation (ACT) procedure, is a more sophis-
ticated and cost-intensive two-step surgical approach.
Using technological advances, a three-dimensional (3D),
biocompatible scaffold as carrier for cell growth is seeded
with chondrocytes from an initial arthroscopy, and is im-
planted by mini-arthrotomy4,5.
Both techniques are used for the treatment of full-
thickness cartilage defects to improve clinical symptoms
and possibly avoid further damage to the knee joint. With re-
gard to the clinical outcome, both treatment options show
promising results6e12. Histological ﬁndings of repair tissue
biopsies obtained during follow-up arthroscopy, however,
vary. After MFX cartilage repair, tissue has been mostly
1220 G. H. Welsch et al.: Multimodal evaluation of cartilage repairreported as ﬁbrocartilage, whereas, after MACT, tissue has
been characterized as hyaline like6,9,12e14. As invasive car-
tilage biopsies are not practical for routine follow-up after
cartilage repair, magnetic resonance imaging (MRI) has be-
come the standard of choice15,16. Conventional MRI has
been shown to be sensitive for the morphological character-
ization after different cartilage repair procedures17e19; how-
ever, MRI is limited in describing the composition of the
cartilage repair tissue20.
For the visualization of cartilage and the cartilage repair
ultrastructure, biochemical MRI has shown increasing
potential, using T1 mapping with delayed gadolinium-
enhanced MRI of the cartilage (dGEMRIC), T1 rho
imaging, or T2-mapping for the assessment of glycosami-
noglycan (GAG)/proteoglycan content and collagen
orientation, respectively21e23. One encouraging alternative
in the evaluation of articular cartilage composition is the
use of diffusion-weighted imaging (DWI), which exploits
the translational motion of water protons24,25. Intra- and ex-
tra-cellular barriers inﬂuence this molecular movement and
therefore it reﬂects changes of the biochemical structure
and architecture of the tissue. This was shown in in-vitro
studies for biochemical structure by Burstein et al.26 which
observed an 20% increased diffusivity after trypsin-induced
loss of proteoglycans and for micro structural changes by
Mylnarik et al.25 in cartilage with intact surface and early de-
generation. In a recent study, a relatively fast, steady-state,
free precession (SSFP) approach of semi-quantitative as-
sessment of diffusivity could be applied in-vivo and showed
promising results for the evaluation of cartilage repair27.
The aim of this cross-sectional pilot study was to com-
pare clinical scoring, morphological MR evaluation and es-
pecially biochemical T2-mapping and DWI in their ability to
assess differences between MFX and MACT at different
time points after surgery. This was done for each parameter
separately and in correlation to assess their combined value
in monitoring cartilage reparative procedures.Materials and methodsPATIENT POPULATIONTwenty patients (eight females, 12 males; mean age, 35.6 8.9 years;
age range, 20e52 years) were enrolled in this study. Ten patients were
treated with MFX, and ten were treated with MACT. Groups were matched
post-operative interval (matching criterion 1) and age (matching criterion 2)
retrospectively from a larger cohort. Furthermore the post-operative follow-
up had to be at a minimum interval of 12 months, to reduce the inclusion
of changes in biochemical MR parameters due to repair tissue matura-
tion27,28. The medical university ethics commission provided ethical approval
for this study, and written informed consent was obtained from all patients
prior to enrollment in the study. All patients were treated for a single, symp-
tomatic full-thickness cartilage defect on one femoral condyle. Exclusion cri-
teria were advanced osteoarthritis on X-ray by presences of secondary OA
signs according to KellgreneLawrence grading (>grad 1), instability, and ad-
ditional injury of the lower extremity that was documented by clinical exam-
ination, conventional radiographs, and MRI.
The MFX group consisted of three women and seven men with a mean
age of 36.0 10.4 years and a post-operative interval of, 32.6 16.7 months
(range, 12e63). Defect size was 3.37 1.61 cm2. The MACT group con-
sisted of ﬁve men and ﬁve women with a mean age of 35.1 7.7 years
and a post-operative interval of 31.7 18.3 months (range, 12e59). Defect
size was 4.99 2.02 cm2. For MACT, HyalograftC, a hyaluronan-based
scaffold (Fidia Advanced Biopolymers, Abano Terme, Italy), was used. The
body-mass index of 23.2 kg/m2 for the group after MFX and 24.5 kg/m2 for
the group after MACT was comparable between the groups, however, it
was not used to match the patients.IMAGE ACQUISITIONMR imaging was performed on a 3 T MR scanner (Magnetom Trio, Sie-
mens Medical Solutions, Erlangen, Germany) with a gradient strength of40 mT/m using a dedicated eight-channel knee coil (In-vivo, Gainesville,
FL, USA). All patients were positioned consistently with the joint space in
the middle of the coil and the knee extended in the coil. Patients were
scanned after at least half an hour of rest to minimize possible hydration ef-
fects because of different weight bearing/exercise before the MR evaluation.
The protocol for all patients was identical, and consisted of a morpho-
logical, isotropic 3D-double echo steady-state (DESS) sequence, a 2D
multi-echo spin-echo (SE) sequence using six echoes for the standard
T2-mapping, and a 3D partially balanced, steady-state gradient-echo pulse
sequence with diffusion weighting [diffusion-weighted reversed FISP = fast
imaging with steady state precession (DW-PSIF)] for DWI. After localizing
the whole knee joint was scanned using a morphological isotropic DESS
sequence with a repetition time (TR) of 15.1 ms, echo time (TE) 5.11 ms
and ﬂip angle of 25. Field-of-view (FoV) was 160 160 mm, the pixel
matrix was 256 256, and the voxel size was 0.6 0.6 0.6 mm. The
bandwidth (BW) was 230 Hz/pixel, the number of averages was one,
with 104 slices, and the total scan time was 6:32 min. After multiplanar re-
construction using a 3D viewing tool on a Leonardo workstation (Siemens
Medical Solutions, Erlangen, Germany) and together with the provided
surgical reports, the cartilage repair area was identiﬁed and subsequent
T2-mapping and DWI sequences were planned in the sagittal direction.
The subsequent SE-T2 acquisition used a TR of 1.650 s and six TEs of
12.9 ms, 25.8 ms, 38.7 ms, 51.6 ms, 65.5 ms, and 77.4 ms. FoV was
160 160 mm, pixel matrix was 320 320 and voxel size was
0.5 0.5 3.0 mm. The ﬂip angle was 180, the BW was 230 Hz/pixel, the
number of averages was one, with six slices, and the total acquisition time
was 4:45 min. Imaging parameters for the DW-PSIF acquisition utilized
a TR of 16.3 ms and a TE of 6.1 ms. FoV was 160 160 mm, pixel matrix
was 320 320 and voxel size was 0.5 0.5 3.0 mm. The ﬂip angle was
30, the BW was 150 Hz/pixel, and the number of averages was one, with
six slices. In order to allow a semi-quantitative assessment of the diffusional
behavior within articular cartilage, the diffusion sequence protocol consisted
of two separate but immediately consecutive measurements using none (0),
and 75 mTmsm1 monopolar diffusion gradient moments oriented in phase
direction for DWI and otherwise identical imaging parameters. The diff-sen-
sitizing gradient was directed perpendicular (central part, weight-bearing
zone, area of analyzed cartilage repair tissue and control cartilage) to oblique
(more posterior part) to the cartilage surface in the femoral condyle. Acquisi-
tion time was two times 3:30 min.DATA ANALYSISClinical evaluation
Clinical outcomes for each patient were assessed, using the Lysholm
score29,30, a knee scoring system that includes eight sub-criteria, three of
which were functional and ﬁve of which were subjective. With a total of
100 possible points that can be achieved, the Lysholm knee scale is a condi-
tion-speciﬁc outcome measure validated for chondral disorders of the
knee31. Clinical testing was performed at the same day as MRI examination.
Morphological evaluation
The complete analysis was carried out by an experienced senior muscu-
loskeletal radiologist, in consensus with an orthopedic surgeon with a special
interest in musculoskeletal MRI. Morphological evaluation was achieved us-
ing the isotropic DESS sequence for the magnetic resonance observation of
cartilage repair tissue (MOCART) scoring system32. This point scoring sys-
tem was designed to systematically record the constitution of the area of car-
tilage repair and surrounding tissues, and has been shown to be reliable and
reproducible and can be applied to different surgical cartilage repair tech-
niques5,16. The maximum score achievable in the evaluation of nine
variables is 100.
Biochemical evaluation e T2
Biochemical assessment was done by a region of interest (ROI) analysis.
ROIs were placed in the central part of the cartilage repair tissue and a car-
tilage site morphologically seen as healthy articular cartilage as an internal
control. ROIs had to cover the full thickness of cartilage repair tissue and
the full thickness of internal control cartilage for T2 and DWI evaluation.
Both cartilage sites of interest were analyzed on two contiguous sagittal sli-
ces, and localization of cartilage repair tissue, as well as healthy cartilage,
were again conﬁrmed by surgical reports. As all cartilage repair sites were
located within the weight-bearing zone of one femoral condyle, ROIs of
healthy appearing cartilage could also be placed within the weight-bearing
zone. This ensured biomechanical comparability and avoided alterations of
T2 values due to the magic angle effect. ROI evaluations were obtained di-
rectly from calculated parametric maps. T2 maps were obtained using
a pixel-wise, mono-exponential, non-negative least squares (NNLS) ﬁt anal-
ysis with noise ﬂoor correction. Quantitative T2 values (ms) were analyzed.
Fig. 1. Morphological isotropic 3D e DESS sequence used for the MOCART score of a patient after MFX. Sagittal (a) and coronal (b) recon-
struction focused on the cartilage repair area (arrows). The MOCART scoring showed with 85 points complete repair ﬁlling, intact integration
and surface, slightly altered structure and altered subchondral lamina and bone.
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For analysis of the steady-state DWI a semi-quantitative approach was
used, because in contrary to the well known Stejskal-Tanner diffusion acqui-
sition scheme for signal attenuation in the presence of diffusion by employing
two gradient pulses in spin-echo based sequences, the signal dependence
of steady-state sequences has a complex dependence on a, T1, T2, TR
and the single diffusion-sensitizing gradient and is thus difﬁcult to quantify33.
Therefore a semi-quantitative value of diffusivity based a quotient image of
the two PSIF sequences (non-diffusion weighted divided by diffusion-
weighted image) was calculated using the built-in software routines of the
clinical scanner27. Thus diffusion-quotients analyzed are semi-quantitative
and show no unit.
ROIs for DWI and T2 were also divided into deep (50%) and superﬁcial
(50%) aspects with regard to a known spatial variation for healthy T2
values34. For better comparability with other scoring systems and a clearer
statement about the biochemical constitution of the cartilage repair site,
the biochemical values for cartilage repair tissue within each patient were
evaluated against healthy articular cartilage. Therefore, full-thickness mean
values of cartilage repair sites were divided by full-thickness mean values
of healthy cartilage for a T2 and a DWI index.STATISTICAL ANALYSISQuantitative evaluation was accomplished by analysis of variance using
a three-way analysis of variance (ANOVA) with random factors, consider-
ing the fact of different measurements within each patient or control. The
spatial variation between the cartilage layers was assessed by a three-way
ANOVA with random effects with two repeated measures factors. For cor-
relations, the Pearson coefﬁcient was used; correlation plots with a 95%
conﬁdence interval are given. SPSS version 15.0 (SPSS Institute, Chi-
cago, IL, USA) for Windows (Microsoft, Redmont, WA, USA) was used,
and differences with a P value less than 0.05 were considered as statisti-
cally signiﬁcant.ResultsCLINICAL EVALUATIONClinical outcome assessments of both patient groups,
based on Lysholm scoring, showed no signiﬁcant differences
(P¼ 0.420). In patients after MFX, the Lysholm score for all
patients was 80.5 15.6, ranging from 59 to 100. After
MACT, the Lysholm score for all patients was 83.4 11.7,
ranging from 62 to 100.MORPHOLOGICAL EVALUATIONUsing the MOCART scoring system, there were no signif-
icant differences (P¼ 0.209) found between the different
cartilage repair techniques. For patients after MFX, a score
of 75.0 12.0, ranging from 50 to 90, could be assessed. In
patients after MACT, however, the MOCART score was
75.5 13.0, ranging from 50 to 90. Figures 1 and 2 illustrate
the morphological isotropic 3D-DESS imaging characteris-
tics of a patient after MFX (Fig. 1) and a patient after
MACT (Fig. 2).BIOCHEMICAL EVALUATION e T2With regard to T2-mapping, mean values of healthy artic-
ular cartilage sites were comparable and showed no
signiﬁcant differences (P¼ 0.899) between MFX
(53.7 ms 8.9 ms) and MACT (54.0 ms 8.8 ms). Both
groups also showed a highly signiﬁcant increase in T2
values from deep to superﬁcial aspects of healthy cartilage
sites. For MFX patients, T2 values of healthy control carti-
lage increased from 50.3 ms 8.7 ms to 57.2 ms 10.5 ms
(P< 0.001), and for MACT patients, T2 values of normal
control cartilage increased from 50.9 ms 7.6 ms to
57.1 ms 11.2 ms (P< 0.001).
The mean T2 values for cartilage repair areas after
MFX (47.9 ms 9.8 ms) were signiﬁcantly lower com-
pared to mean T2 values after MACT (53.6 ms 11.9 ms)
(P¼ 0.039). Within MFX patients, regions of cartilage re-
pair tissue showed signiﬁcantly reduced mean T2 values
compared to internal healthy control cartilage
(P< 0.001), whereas, within MACT patients, no difference
was observed (P¼ 0.747). Looking at the spatial varia-
tion, values for MFX showed no signiﬁcant increase
from deep (47.3 ms 10.1 ms) to superﬁcial
(48.5 ms 9.8 ms) (P¼ 0.352), whereas, cartilage repair
tissue after MACT showed a slightly signiﬁcant increase
in T2 values from deep (51.9 ms 12.5 ms) to superﬁcial
(55.1 ms 12.7 ms) (P¼ 0.037).
Fig. 2. Morphological isotropic 3D e DESS sequence used for MOCART score of a patient after MACT. Sagittal (a) and coronal (b) recon-
struction focused on the cartilage repair area (arrows). The MOCART scoring showed with 90 points complete repair ﬁlling, intact integration
and surface, homogen structure and altered subchondral lamina and bone.
1222 G. H. Welsch et al.: Multimodal evaluation of cartilage repairWith regard to the described T2 index, a signiﬁcant differ-
ence (P¼ 0.007) could be seen between MFX (0.89 0.12)
and MACT (0.99 0.16).BIOCHEMICAL EVALUATION e DWIFor DWI, constant values with no signiﬁcant difference
(0.813) could be observed within healthy cartilage sites in pa-
tients who had undergone MFX (1.29 0.14) and MACT
(1.28 0.14) procedures. A slight but not signiﬁcant zonal in-
crease could be seen between the deep and superﬁcial as-
pects of healthy articular cartilage in MFX patients (deep:
1.28 0.22; superﬁcial: 1.32 0.17; P¼ 0.470) and MACT
patients (deep: 1.26 0.19; superﬁcial: 1.32 0.17;
P¼ 0.177). Mean values for cartilage repair tissue showed
no signiﬁcant difference in diffusivity between MFX
(1.50 0.27) and MACT (1.44 0.24) (P¼ 0.375); however,
compared to the internal healthy control cartilage, the cartilage
repair sites showed signiﬁcantly higher diffusivity within MFXFig. 3. Quantitative maps of the same patient (Fig. 1) after MFX for diffusio
area marked by arrows and the ROIs plotted for cartilage repair tissue and
T2 values (blue) within the cartilage repair tissue compared to the surroun
within the trochlea with prolonged T2 values. Short T2 values within the dopatients (P¼ 0.001) and within MACT patients (P¼ 0.007).
With regard to spatial variation, no signiﬁcant distribution could
be found between deep and superﬁcial aspects of cartilage re-
pair tissue in MFX patients (deep: 1.55 0.45; superﬁcial:
1.44 0.17; P¼ 0.147) and MACT patients (deep:
1.46 0.23; superﬁcial: 1.42 0.29; P¼ 0.330).
The DWI index showed slightly but not signiﬁcantly higher
values for MFX (1.17 0.26) compared to MACT
(1.13 0.23) (P¼ 0.549).
The biochemical DWI and T2 maps are shown in Figs. 3
and 4 for a patient after MFX (Fig. 3) and MACT (Fig. 4)
(same patient as Figs. 1 and 2 for comparison). The graphs
in Fig. 5 are visualizing the DWI and the T2 index related to
the post-operative follow-up after MFX and after MACT.CORRELATIONSTo achieve high enough power with correlations, all 20
patients were combined. The Lysholm score correlatedn-weighted imaging (a) and T2-mapping (b) with the cartilage repair
healthy control cartilage. Visible higher diffusivity (red) and shorter
ding cartilage. For the T2 map, a magic angle effect is likely visible
rsal part of the femoral condyle can be due to partial volume effect.
Fig. 4. Quantitative maps of the same patient (Fig. 2) after MACT for diffusion-weighted imaging (a) and T2-mapping (b) with the cartilage
repair area marked by arrows and the ROIs marked for the repair tissue and the control cartilage. Visible slightly higher diffusivity (red)
and unchanged T2 values (blue) within the cartilage repair tissue compared to the surrounding cartilage. Nevertheless, the prolonged T2
values within the cartilage surface can also be due to partial volume effects.
1223Osteoarthritis and Cartilage Vol. 17, No. 9signiﬁcantly (P¼ 0.031) with the MOCART, with a Pearson
coefﬁcient of 0.484. For biochemical parameters, the
Lysholm score was seen to correlate weakly, but not signif-
icantly (P¼ 0.193), with the reported T2 index (Pearson
coefﬁcient 0.304). The reported DWI index correlated
signiﬁcantly (P¼ 0.011) with the Lysholm score (Pearson
coefﬁcient 0.557). No correlation was found between
the MOCART score and the biochemical parameters. No
correlation was found between T2 and DWI. For visualiza-
tion correlation plots with 95% conﬁdence interval are
given in Fig. 6.
Tables I and II represent the clinical, MR-morphological,
and MR-biochemical values for single patients after MFX
(Table I) and MACT (Table II).
Discussion
The post-operative evaluation of cartilage repair proce-
dures is essential for patient care, as well as for theFig. 5. The graphs show the DWI index (left, black, circles, continuous lin
patient related to the post-operative interval after MFX (a) and MACT (b).
added with its slope (R Sq linear). It is visualized that after MFX, the DW
whereas the T2 index remains stable on a low level. In contrast to that
decreases on a hcharacterization of the quality of the respective surgical treat-
ment. Unquestionably, the clinical condition and the content-
ment of the patient postoperatively are the primary criteria of
procedural success. However, to objectively evaluate the
surgical outcome over time, more scientiﬁc criteria are re-
quired. In addition to the condition of the ligaments, menisci,
and surrounding cartilage, an assessment of the status of
cartilage repair tissue is crucial, especially in longitudinal fol-
low-up evaluation. Morphological MRI is able to provide
information about the morphological constitution of the carti-
lage repair area, as well as the adjacent articular cartilage.
The goal of the MRI exam should be to evaluate graft
incorporation, defect ﬁlling, and the spatial condition
(boneecartilage, cartilageecartilage-interfaces), signal
characteristics, and changes in the graft and nearby tissues,
such as possible cleft formation or delamination16. A pub-
lished protocol that considers thesemorphologic imaging pa-
rameters is the MOCART scoring system32. In our study, the
MOCART score correlated signiﬁcantly with the clinicale) and the T2 index (right, grey, triangles, and dotted line) for every
Furthermore to show the progression over time, a regression line is
I index, according to its ﬁtting line, is increasing and thus diffusivity,
after MACT, the DWI index remains stable, whereas the T2 index
igher level.
Fig. 6. Correlation plots with 95% conﬁdence interval of the Ly-
sholm score and the MOCART score (r¼ 0.484; P¼ 0.031) (a);
the Lysholm score and the T2 index (r ¼ 0.304; P¼ 0.193) (b)
and the Lysholm score and the DWI index ( r ¼0.557;
P¼ 0.011) (c).
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after MACT.Marlovits et al.17 also found that different param-
eters from the MOCART score, such as defect ﬁlling and the
structure of repair tissue or its signal intensity, to signiﬁcantly
correlate with clinical scores in patients after ACT. In a pro-
spective study after MFX, Mithoefer et al.18 also found vol-
ume ﬁlling of the defect by repair cartilage to signiﬁcantly
correlate with objective clinical parameters. Nevertheless,
in our study, no separation or differentiation between MFX
andMACT was possible based on the clinical Lysholm score
or the MR-morphological MOCART score.
In a well-recognized study by Knutsen et al., who com-
pared a total of 80 patients after MFX and autologous chon-
drocyte implantation (ACI) in a two-year12 and ﬁve-year11
follow-up, no signiﬁcant difference was found between out-
comes for either procedure, based on clinical evaluation
and conventional radiographic techniques; however, noMRI was obtained. This could mean that either both surgical
treatments actually have the same outcome or that a differ-
entiation happens after a longer follow-up period and
maybe more sensitive outcome measures are needed.
Kreuz et al., on the other hand, reported a deterioration of
clinical results in MFX patients beginning at 18 months after
surgery35. Histological reports, as the gold standard in stud-
ies after MFX and MACT, show varying results6,9,11e14.
Nevertheless, after MFX, most histological evaluations re-
port ﬁbrocartilage, whereas, after MACT or comparable car-
tilage transplantation techniques, histological results are
often reported as hyaline like. In his recent article, Knutsen
et al.11 reports no correlation between histological ﬁndings
and clinical outcome, but in the reported failures, primarily
ﬁbrocartilage (and never hyaline cartilage) was found.
Thus T2-mapping and DWI may provide additional informa-
tion in the noninvasive evaluation of cartilage repair tissue
ultrastructure.
In the present study, two cartilage repair procedures were
compared using T2-relaxation and diffusion-weighted imag-
ing of articular cartilage and cartilage repair. Both
techniques showed different results. T2-mapping demon-
strated that T2-relaxation was higher in cartilage repair tis-
sue after MACT compared to MFX. When the zonal
evaluation was considered, cartilage repair tissue after
MACT seemed to be more similar to native hyaline cartilage
than repair tissue after MFX. This proposition is strength-
ened by an animal study by White et al.36, who found a sig-
niﬁcant zonal increase in T2 values in cartilage repair tissue
after osteochondral autograft transplantation (OAT), but not
after MFX, using polarized light microscopy in histological
samples.
Zonal assessment of DWI results showed no signiﬁcant
differences between MFX and MACT repair tissue. How-
ever, mean diffusion values, were able to distinguish be-
tween healthy cartilage sites and cartilage repair tissue. A
differentiation between cartilage repair tissue after MFX
and MACT, however, was not possible, although the diffu-
sivity of cartilage repair tissue after MFX was higher than
that after MACT.
DWI is based on the molecular motion of water inﬂuenced
by cellular barriers; thus, by measuring the molecular move-
ment, the biochemical structure and architecture of the spe-
ciﬁc tissue is reﬂected25,37,38. Furthermore, there are in-vitro
studies that report a zonal pattern of diffusion cartilage im-
aging39, as well as a dependency of the diffusivity on artic-
ular cartilage and the collagen framework40. In earlier
studies, this reliance on cartilage ultrastructure was not
evaluated so as to possibly detect early cartilage matrix
damage25. A more often reported and used biochemical
MRI approach is T2-relaxation23,41e43. A clear dependency
on collagen structure, as well as water content, has been
reported, and the spatial variation in T2 values has been at-
tributed to this dependency34,42. In our study, no correlation
was found between T2 and DWI. This could be attributable
to an insufﬁcient signal-to-noise ratio or be a by-product of
the relatively small patient number; otherwise, it could
also be that T2-mapping and DWI image different compo-
nents of articular cartilage and cartilage repair tissue. Histo-
logical proof, as well as quantiﬁcation using apparent
diffusion constant (ADC) values, is required in future studies
to determine this. Nevertheless, in the present evaluation,
a signiﬁcant correlation was found between the DWI index
and the clinical outcome, using the Lysholm score. This
maybe as attributable to a correlation between structural
changes within the repair tissue and the clinical condition
of a patient. Hence as proposed within in-vitro studies25,26,
Table I
Patients after MFX. Clinical Lysholm score, MR-morphological MOCART score, MR-biochemical T2 and DWI values for internal control
cartilage (control) and cartilage repair tissue (TX). T2 and DWI index calculated as TX/control
Patient Age Follow-up Lysholm MOCART T2 control T2 TX T2 index DWI control DWI TX DWI index
1 32 12 100* 75 68.1 63.4 .93 1.35 1.54 1.15
2 46 19 81 60 57.4 52.9 .92 1.27 1.46 1.16
3 46 19 59y 50 56.0 48.4 .87 1.34 1.68 1.26
4 32 23 95 90 38.9 30.4 .78 1.26 1.49 1.19
5 33 24 90 70 57.8 48.6 .84 1.30 1.38 1.06
6 41 29 63 75 57.1 48.7 .85 1.26 1.33 1.05
7 22 41 85 85 47.3 48.3 1.03 1.39 1.41 1.05
8 52 42 100* 85 57.7 56.4 .98 1.25 1.31 1.04
9 20 54 73 85 40.6 37.3 .92 1.33 1.85 1.40
10 36 63 59y 75 56.5 44.5 .79 1.23 1.60 1.37
Patients in order of the post-operative follow-up. Age in years. Post-operative follow-up in months. T2 values in ms.
*Light grey background representing best clinical outcome.
yDark grey background representing worst clinical outcome.
1225Osteoarthritis and Cartilage Vol. 17, No. 9DWI might be able to mirror the biochemical constitution of
cartilage as a combination of collagen content/orientation,
hydration as well as glycosaminoglycan content. It is not
sensitive to one particular biomarker, but as degeneration
and restitution of cartilage are a combined process of these
extra-cellular components, it has the potential to grade
these changes in combination. However, for a deﬁnitive
statement about this, a larger number of patients and further
evaluations are needed. Thus, the limitations of this study
are the small patient numbers and the lack of histological
samples, as well as the semi-quantitative approach for
DWI. On the other hand, the trend toward a high T2 index,
together with a high Lysholm score, was not signiﬁcant.
Within this correlation, a clear limitation is the evaluation
in a small patient number and within two cartilage repair
therapies. Especially for the T2 index this can be seen as
problematic as especially within cartilage repair tissue after
MACT it is questionable if a high T2 index really is desirable
or just a cause of maturation. Within MFX to reach a T2 in-
dex near one is surely preferable as shown by Domayer
and co-workers44. The correlation between a clinical param-
eter and the MOCART score was also described before
by Marlovits et al.17 and strengthens this multimodal
approach.
Furthermore as seen in Figs. 3 and 4, only one quanti-
tative map of a patient after MFX or MACT might be not
enough to really state the constitution of the repair tissue
and of the adjacent cartilage. Hence, the results cannotTable I
Patients after MACT. Clinical Lysholm score, MR-morphological MOCA
cartilage (control) and cartilage repair tissue (TX).
Patient Age Follow-up Lysholm MOCART T2 control
1 25 12 74 85 70.2
2 32 14 84 80 51.7
3 36 15 100* 90 59.6
4 50 20 62y 80 55.2
5 36 27 88 80 36.3
6 36 29 84 80 51.2
7 33 31 71 60 49.2
8 28 51 81 70 60.9
9 28 59 100* 90 51.5
10 39 59 90 70 54.6
Patients in order of the post-operative follow-up. Age in years. Post-op
*Light grey background representing the best clinical outcome.
yDark grey background representing the worst clinical outcome.deﬁnitively state whether the DWI index or the T2 index re-
ally correlates with clinical outcome or the ultrastructure of
the repair tissue, but the potential additional information
about cartilage repair tissue that could be obtained with
this ‘‘virtual biopsy’’ maybe important for future studies of
different cartilage repair procedures. This gets even
more visible when looking at Fig. 5 where the DWI index
and the T2 index is related to the post-operative follow-
up time points. E.g., available studies state that over
time and beginning with a post-operative follow-up of
more than 18 months, the clinical results after MFX dete-
riorate35. This might be visualized by the increase in diffu-
sivity within the longer follow-up intervals. The stable and
low T2 index might be due to mature ﬁbrocartilage. In con-
trast, the decrease of the overall higher T2 values might
visualize the ongoing maturation process after MACT
and the constant diffusivity could be an indicator for the
stable, possibly hyaline like, structure of the
cartilage repair tissue after MACT. Nevertheless the pa-
tient cohort stays small and these ﬁndings are just
descriptive.
The decision to use the biochemical methodologies T2
and DWI within this study was based on their possible
practicability in clinical routine follow-up, as no contrast
agent administration is necessary and a statement on
the ultrastructure of the repair tissue can be achieved. To-
gether with morphological MR scoring (MOCART) and clin-
ical scoring (Lysholm) it might be a suggestion for anI
RT score, MR-biochemical T2 and DWI values for internal control
T2 and DWI index calculated as TX/control
T2 TX T2 index DWI control DWI TX DWI index
77.8 1.11 1.29 1.47 1.14
46.6 .90 1.29 1.37 1.08
63.5 1.07 1.22 1.30 1.11
53.3 .97 1.37 1.75 1.32
40.4 1.13 1.28 1.32 1.04
61.0 1.20 1.28 1.40 1.12
36.4 .74 1.27 1.40 1.11
52.8 .87 1.34 1.64 1.23
48.8 .95 1.32 1.41 1.09
54.9 1.01 1.23 1.39 1.14
erative follow-up in months. T2 values in ms.
1226 G. H. Welsch et al.: Multimodal evaluation of cartilage repairadvanced multimodal approach in the daily routine follow-
up of patients after sophisticated cartilage repair
procedures.
This study demonstrated that, besides clinical scoring
and morphological MRI, T2-relaxation and diffusion-
weighted imaging might provide additional information in
the follow-up after cartilage repair procedures. T2-mapping
was shown to be able to reveal differences between the car-
tilage repair tissue generated after MFX and MACT; future
studies have to show if T2 is really able to differentiate
between MFX and MACT. DWI was able to differentiate
between healthy cartilage and cartilage repair tissue and
could be correlated to a widely accepted clinical score. Fur-
ther studies should work to conﬁrm a predictive value for
biochemical MR imaging in the long-term outcome of
cartilage repair procedures.Conﬂict of interest
All authors disclose that no ﬁnancial and personal rela-
tionships with other people or organizations that could inap-
propriately inﬂuence (bias) their work was given.Acknowledgments
Funding for this study was provided by Austrian Science
Fund (FWF) FWF-TRP-Project L243-B15.References
1. Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects:
study of 25,124 knee arthroscopies. Knee 2007;14:177e82.
2. Steadman JR, Rodkey WG, Briggs KK. Microfracture to treat full-
thickness chondral defects: surgical technique, rehabilitation, and out-
comes. J Knee Surg 2002;15:170e6.
3. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical tech-
nique and rehabilitation to treat chondral defects. Clin Orthop Relat
Res 2001;S362e369.
4. Brittberg M. Autologous chondrocyte transplantation. Clin Orthop Relat
Res 1999;S147e155.
5. Marlovits S, Zeller P, Singer P, Resinger C, Vecsei V. Cartilage repair:
generations of autologous chondrocyte transplantation. Eur JRadiol
2006;57:24e31.
6. Bartlett W, Skinner JA, Gooding CR, Carrington RW, Flanagan AM,
Briggs TW, et al. Autologous chondrocyte implantation versus ma-
trix-induced autologous chondrocyte implantation for osteochondral
defects of the knee: a prospective, randomised study. J Bone Joint
Surg Br 2005;87:640e5.
7. Behrens P, Bitter T, Kurz B, Russlies M. Matrix-associated autologous
chondrocyte transplantation/implantation (MACT/MACI)e5-year fol-
low-up. Knee 2006;13:194e202.
8. Bentley G, Biant LC, Carrington RW, Akmal M, Goldberg A,
Williams AM, et al. A prospective, randomised comparison of autolo-
gous chondrocyte implantation versus mosaicplasty for osteochondral
defects in the knee. J Bone Joint Surg Br 2003;85:223e30.
9. Gudas R, Kalesinskas RJ, Kimtys V, Stankevicius E, Toliusis V,
Bernotavicius G, et al. A prospective randomized clinical study of mo-
saic osteochondral autologous transplantation versus microfracture
for the treatment of osteochondral defects in the knee joint in young
athletes. Arthroscopy 2005;21:1066e75.
10. Horas U, Pelinkovic D, Herr G, Aigner T, Schnettler R. Autologous chon-
drocyte implantation and osteochondral cylinder transplantation in
cartilage repair of the knee joint. A prospective, comparative trial.
J Bone Joint Surg Am 2003;85-A:185e92.
11. Knutsen G, Drogset JO, Engebretsen L, Grontvedt T, Isaksen V,
Ludvigsen TC, et al. A randomized trial comparing autologous chon-
drocyte implantation with microfracture. Findings at ﬁve years.
J Bone Joint Surg Am 2007;89:2105e12.
12. Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T,
Solheim E, et al. Autologous chondrocyte implantation compared
with microfracture in the knee. A randomized trial. J Bone Joint
Surg Am 2004;86-A:455e64.13. D’Anchise R, Manta N, Prospero E, Bevilacqua C, Gigante A. Autolo-
gous implantation of chondrocytes on a solid collagen scaffold: clinical
and histological outcomes after two years of follow-up. J Orthopaed
Traumatol 2005;6:36e43.
14. Zheng MH, Willers C, Kirilak L, Yates P, Xu J, Wood D, et al. Matrix-
induced autologous chondrocyte implantation (MACI): biological and
histological assessment. Tissue Eng 2007;13:737e46.
15. Alparslan L, Winalski CS, Boutin RD, Minas T. Postoperativ magnetic
resonance imaging of articular cartilage repair. Semin Musculoskelet
Radiol 2001;5:345e63.
16. Trattnig S, Millington SA, Szomolanyi P, Marlovits S. MR imaging of os-
teochondral grafts and autologous chondrocyte implantation. Eur Ra-
diol 2007;17:103e18.
17. Marlovits S, Singer P, Zeller P, Mandl I, Haller J, Trattnig S. Magnetic
resonance observation of cartilage repair tissue (MOCART) for the
evaluation of autologous chondrocyte transplantation: determination
of interobserver variability and correlation to clinical outcome after 2
years. Eur J Radiol 2006;57:16e23.
18. Mithoefer K, Williams 3rd RJ, Warren RF, Potter HG, Spock CR,
Jones EC, et al. The microfracture technique for the treatment of artic-
ular cartilage lesions in the knee. A prospective cohort study. J Bone
Joint Surg Am 2005;87:1911e20.
19. Ramappa AJ, Gill TJ, Bradford CH, Ho CP, Steadman JR. Magnetic res-
onance imaging to assess knee cartilage repair tissue after microfrac-
ture of chondral defects. J Knee Surg 2007;20:228e34.
20. Tins BJ, McCall IW, Takahashi T, Cassar-Pullicino V, Roberts S,
Ashton B, et al. Autologous chondrocyte implantation in knee joint:
MR imaging and histologic features at 1-year follow-up. Radiology
2005;234:501e8.
21. Borthakur A, Mellon E, Niyogi S, Witschey W, Kneeland JB, Reddy R.
Sodium and T1rho MRI for molecular and diagnostic imaging of artic-
ular cartilage. NMR Biomed 2006;19:781e821.
22. Burstein D, Velyvis J, Scott KT, Stock KW, Kim YJ, Jaramillo D, et al.
Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI: (dGEM-
RIC) for clinical evaluation of articular cartilage. Magn Reson Med
2001;45:36e41.
23. Mosher TJ, Dardzinski BJ. Cartilage MRI T2 relaxation time mapping:
overview and applications. Semin Musculoskelet Radiol 2004;8:
355e68.
24. Miller KL, Hargreaves BA, Gold GE, Pauly JM. Steady-state diffusion-
weighted imaging of in vivo knee cartilage. Magn Reson Med 2004;
51:394e8.
25. Mlynarik V, Sulzbacher I, Bittsansky M, Fuiko R, Trattnig S. Investigation
of apparent diffusion constant as an indicator of early degenerative
disease in articular cartilage. J Magn Reson Imaging 2003;17:440e4.
26. Burstein D, Gray ML, Hartman AL, Gipe R, Foy BD. Diffusion of small
solutes in cartilage as measured by nuclear magnetic resonance
(NMR) spectroscopy and imaging. J Orthop Res 1993;11:465e78.
27. Mamisch TC, Menzel MI, Welsch GH, Bittersohl B, Salomonowitz E,
Szomolanyi P, et al. Steady-state diffusion imaging for MR in-vivo
evaluation of reparative cartilage after matrix-associated autologous
chondrocyte transplantation at 3 tesla-Preliminary results. Eur J
Radiol 2008;65:72e9.
28. Trattnig S, Mamisch TC, Welsch GH, Glaser C, Szomolanyi P,
Gebetsroither S, et al. Quantitative T2 mapping of matrix-associated
autologous chondrocyte transplantation at 3 Tesla: an in vivo cross-
sectional study. Invest Radiol 2007;42:442e8.
29. Lysholm J, Gillquist J. Evaluation of knee ligament surgery results with
special emphasis on use of a scoring scale. Am J Sports Med
1982;10:150e4.
30. Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament
injuries. Clin Orthop Relat Res 1985;43e9.
31. Kocher MS, Steadman JR, Briggs KK, Sterett WI, Hawkins RJ. Reliabil-
ity, validity, and responsiveness of the Lysholm knee scale for various
chondral disorders of the knee. J Bone Joint Surg Am 2004;86-A:
1139e45.
32. Marlovits S, Striessnig G, Resinger CT, Aldrian SM, Vecsei V, Imhof H,
et al. Deﬁnition of pertinent parameters for the evaluation of articular
cartilage repair tissue with high-resolution magnetic resonance imag-
ing. Eur J Radiol 2004;52:310e9.
33. Deoni SC, Peters TM, Rutt BK. Quantitative diffusion imaging with
steady-state free precession. Magn Reson Med 2004;51:428e33.
34. Smith HE, Mosher TJ, Dardzinski BJ, Collins BG, Collins CM, Yang QX,
et al. Spatial variation in cartilage T2 of the knee. J Magn Reson Im-
aging 2001;14:50e5.
35. Kreuz PC, Steinwachs MR, Erggelet C, Krause SJ, Konrad G, Uhl M,
et al. Results after microfracture of full-thickness chondral defects in
different compartments in the knee. Osteoarthritis Cartilage 2006;14:
1119e25.
36. White LM, Sussman MS, Hurtig M, Probyn L, Tomlinson G, Kandel R.
Cartilage T2 assessment: differentiation of normal hyaline cartilage
and reparative tissue after arthroscopic cartilage repair in equine sub-
jects. Radiology 2006;241:407e14.
1227Osteoarthritis and Cartilage Vol. 17, No. 937. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, et al.
Diffusion tensor imaging: concepts and applications. J Magn Reson
Imaging 2001;13:534e46.
38. Xia Y, Farquhar T, Burton-Wurster N, Ray E, Jelinski LW. Diffusion and
relaxation mapping of cartilage-bone plugs and excised disks using
microscopic magnetic resonance imaging. Magn Reson Med 1994;
31:273e82.
39. Filidoro L, Dietrich O, Weber J, Rauch E, Oerther T, Wick M, et al.
High-resolution diffusion tensor imaging of human patellar cartilage:
feasibility and preliminary ﬁndings. Magn Reson Med 2005;53:
993e8.
40. Deng X, Farley M, Nieminen MT, Gray M, Burstein D. Diffusion tensor
imaging of native and degenerated human articular cartilage. Magn
Reson Imaging 2007;25:168e71.41. Glaser C. New techniques for cartilage imaging: T2 relaxation time and
diffusion-weighted MR imaging. Radiol Clin North Am 2005;43:
641e53. vii.
42. Goodwin DW, Wadghiri YZ, Dunn JF. Micro-imaging of articular carti-
lage: T2, proton density, and the magic angle effect. Acad Radiol
1998;5:790e8.
43. Nieminen MT, Rieppo J, Toyras J, Hakumaki JM, Silvennoinen J,
Hyttinen MM, et al. T2 relaxation reveals spatial collagen architecture
in articular cartilage: a comparative quantitative MRI and polarized
light microscopic study. Magn Reson Med 2001;46:487e93.
44. Domayer SE, Kutscha-Lissberg F, Welsch G, Dorotka R, Nehrer S,
Gabler C, et al. T2 mapping in the knee after microfracture at 3.0 T:
correlation of global T2 values and clinical outcome e preliminary
results. Osteoarthritis Cartilage 2008;16:903e8.
